Cargando…
Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics
Congenital heart disease (CHD) is the most common birth defect. The prenatal diagnosis of fetal CHD is completely dependent on ultrasound testing, but only ~40% of CHD can be detected. The purpose of this study is to find good biomarkers in amniotic fluid (AF) to detect CHD in the second trimester,...
Autores principales: | Li, Yahong, Sun, Yun, Yang, Lan, Huang, Mingtao, Zhang, Xiaojuan, Wang, Xin, Guan, Xianwei, Yang, Peiying, Wang, Yan, Meng, Lulu, Zhou, Ran, Zhou, Xiaoyan, Luo, Chunyu, Hu, Ping, Jiang, Tao, Xu, Zhengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215886/ https://www.ncbi.nlm.nih.gov/pubmed/34164441 http://dx.doi.org/10.3389/fcvm.2021.671191 |
Ejemplares similares
-
Relationship between amniotic fluid metabolic profile with fetal gender, maternal age, and gestational week
por: Li, Yahong, et al.
Publicado: (2021) -
Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis
por: Yuan, Xuelian, et al.
Publicado: (2022) -
Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy
por: Orczyk-Pawilowicz, Magdalena, et al.
Publicado: (2016) -
Analysis of microbial differences in amniotic fluid between advanced and normal age pregnant women
por: Wang, Ya, et al.
Publicado: (2021) -
Associations between the Level of Trace Elements and Minerals and Folate in Maternal Serum and Amniotic Fluid and Congenital Abnormalities
por: Kocylowski, Rafal, et al.
Publicado: (2019)